These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1992438)

  • 1. Two c-myb proteins differing by their aminotermini exhibit different transcriptional transactivation activities (yeast/reporter-effector system).
    Punyammalee B; Crabeel M; de Lannoy C; Perbal B; Glansdorff N
    Oncogene; 1991 Jan; 6(1):11-9. PubMed ID: 1992438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast.
    Seneca S; Punyammalee B; Sureau A; Perbal B; Dvorák M; Crabeel M
    Oncogene; 1993 Sep; 8(9):2335-42. PubMed ID: 8361752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activation by human c-myb and v-myb genes.
    Kalkbrenner F; Guehmann S; Moelling K
    Oncogene; 1990 May; 5(5):657-61. PubMed ID: 2189102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
    Tantravahi R; Dudek H; Patel G; Reddy EP
    Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
    Patel G; Tantravahi R; Oh IH; Reddy EP
    Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-Myb.
    Matre V; Høvring PI; Fjeldheim AK; Helgeland L; Orvain C; Andersson KB; Gautvik KM; Gabrielsen OS
    Biochem J; 2003 Jun; 372(Pt 3):851-9. PubMed ID: 12628004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.
    Foos G; Natour S; Klempnauer KH
    Oncogene; 1993 Jul; 8(7):1775-82. PubMed ID: 8510924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of fibroblast growth factor 2 expression in melanoma cells by the c-MYB proto-oncoprotein.
    Miglarese MR; Halaban R; Gibson NW
    Cell Growth Differ; 1997 Nov; 8(11):1199-210. PubMed ID: 9372243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-myb proto-oncogene: evidence for intermolecular recombination of coding sequences.
    Vellard M; Soret J; Viegas-Pequignot E; Galibert F; Nguyen VC; Dutrillaux B; Perbal B
    Oncogene; 1991 Apr; 6(4):505-14. PubMed ID: 1840680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
    Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
    Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human c-myb is expressed in cervical carcinomas and transactivates the HPV-16 promoter.
    Nürnberg W; Artuc M; Nawrath M; Lovric J; Stüting S; Moelling K; Czarnetzki BM; Schadendorf D
    Cancer Res; 1995 Oct; 55(19):4432-7. PubMed ID: 7671256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternatively spliced isoform of B-Myb is a transcriptional inhibitor.
    Horstmann S; Ferrari S; Klempnauer KH
    Oncogene; 2000 Nov; 19(48):5428-34. PubMed ID: 11114719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
    Dubendorff JW; Lipsick JS
    Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human A-myb protein is a strong activator of transcription.
    Golay J; Loffarelli L; Luppi M; Castellano M; Introna M
    Oncogene; 1994 Sep; 9(9):2469-79. PubMed ID: 8058310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of a C. elegans GATA transcription factor, ELT-1, expressed in yeast.
    Shim YH; Bonner JJ; Blumenthal T
    J Mol Biol; 1995 Nov; 253(5):665-76. PubMed ID: 7473742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transactivation of the GATA-1 promoter by a myb-ets-containing mouse retrovirus is mediated by CACCC elements.
    Sun-Hoffman L; Aurigemma RE; Sun B; Ruscetti SK
    Oncogene; 1996 Sep; 13(5):1037-42. PubMed ID: 8806693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexibility in the second half-site sequence recognised by the c-Myb R2 domain--in vitro and in vivo analysis.
    Ording E; Bergholtz S; Brendeford EM; Jamin N; Gabrielsen OS
    Oncogene; 1996 Sep; 13(5):1043-51. PubMed ID: 8806694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.